BioSpace22h
After 10 Years of Hard Work, COUR Treads Into Pharma’s Myasthenia Gravis Territory
COUR Pharmaceuticals has been around a while, but not until last year did the company solidify behind its ultimate mission with a series A raise.
manilatimes23h
Health2Sync Deepens Reach and Partnerships in South Korea with Growing Adoption of its Digital Disease Management Platform
Health2Sync Deepens Reach and Partnerships in South Korea with Growing Adoption of its Digital Disease Management Platform ...
The Lancet3h
Non-invasive tests for assessing liver fibrosis and cirrhosis in chronic hepatitis B
Assessment of liver fibrosis and cirrhosis is crucial for the management of patients with chronic hepatitis B. The presence of at least moderate liver fibrosis is an important indication for antiviral ...
Personalized Medicine Biomarkers Market Size to Hit USD 58.39 Billion by 2032, Growing at a 14.54% CAGR – SNS Insider
Rising Demand for Precision Medicine and Advancements in Genomic Technologies Drive Market GrowthPune, Feb. 18, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, The Personalized Medicine Biomarkers ...
Michel Robidoux of Sandoz Canada Elected Chair of Canadian Generic Pharmaceutical Association
The Canadian Generic Pharmaceutical Association (CGPA) is pleased to announce the unanimous election of Michel Robidoux, ...
PharmiWeb10h
Injectable Drug Delivery Market Set for Significant Growth, Projected to Reach USD 113.87 Billion by 2034 at a 8.70% of CAGR
Injectable Drug Delivery MarketThe global injectable drug delivery market is estimated to be valued at USD 49.44 billion in ...
VEA vs VWO: Which International Vanguard ETF Is Worth Owning?
After President Donald Trump’s November 2024 election victory, the Financial Times had reported $140 billion new investment into US equity funds in just the first month. While there is certainly cause ...